Technical considerations in obtaining platelet-rich fibrin for clinical and periodontal research
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
We are writing to you regarding the recent publication by Bains et al.,1 which appeared in your esteemed journal. As a researcher whose studies were cited in this narrative review, we would like to commend the authors for their efforts to contribute to the scientific discourse. Nevertheless, there are a few inaccuracies that I believe should be addressed to enhance the article's precision and reliability.<br/><br/>The first point pertains to the data presented in Table 1. There appears to be a misinterpretation regarding the nomenclature of heated platelet-rich fibrin (PRF). Specifically, the term “Alb-PRF” is attributed to Kawase et al.2 However, their study did not define the PRF membrane post-heating with this nomenclature. It was actually Mourão et al. who, in a 2018 publication, first described the blood by-product, combining the albumin gel with the liquid platelet-rich fibrin, which was obtained through the Medifuge protocol (Silfradent S.r.l., Santa Sofia, Italy) and at that time was called “Alb-CGF”.3 The term “Alb-PRF” was subsequently introduced in a study by Fujioka-Kobayashi et al.,4 and it builds upon the principles set forth by Mourão et al.